In a current go, Cristian Luput, a director at MAIA Biotechnology, Inc. (NYSEAMERICAN:MAIA), has increased his stake in the organization...
MAIA
MAIA Biotechnology, Inc. (NYSE:MAIA) Director Louie Ngar Yee has created a noteworthy expense in the company's inventory, according to a...
In a modern order that indicators assurance in MAIA Biotechnology, Inc. (NYSE:MAIA), director Stan Smith acquired shares worthy of close...
© Reuters. In a the latest transaction, Ramiro Guerrero, a director at MAIA Biotechnology, Inc. (NYSEAMERICAN:MAIA), acquired shares of the...
The trial is intended to assess anti-tumour activity of THIO pursuing PD-L1 procedure in highly developed non-little mobile lung most...
The trial is developed to analyse the anti-tumour exercise of THIO, furthermore Regeneron’s cemiplimab, in NSCLC clients. Credit history: mi_viri...
